Full Breakdown
Mistrust in Healthcare Providers Regarding Cannabis Use During Pregnancy
10/17/2025, 1:23:49 PM
Disconnect Between Patients and Providers
Recent studies indicate a significant disconnect between pregnant individuals and healthcare providers regarding cannabis use during pregnancy. Many patients believe that healthcare providers view cannabis primarily as a harmful recreational substance, leading to a reluctance to disclose their cannabis use. This perception contributes to a growing mistrust in healthcare providers, which can hinder effective communication about treatment options for pregnancy-related symptoms.
According to a study published in *Women’s Health Issues*, pregnant individuals often report using cannabis to manage symptoms related to pregnancy and chronic conditions, despite concerns about potential health risks. The Centers for Disease Control and Prevention (CDC) highlights that cannabis use during pregnancy can lead to adverse outcomes such as low birth weight and neurological development issues in newborns. However, the evolving literature on cannabis and its effects during pregnancy suggests that many patients still seek its benefits.
Patient Perspectives on Provider Interactions
The study's authors conducted interviews with 34 women who had been pregnant within the last two years, revealing that most participants did not disclose their cannabis use to healthcare providers. This lack of communication stems from fears of judgment and potential repercussions, such as being reported to child services. The study identified this phenomenon as "clinical dissonance," where patients perceive cannabis as a medicinal option while providers often categorize it alongside other drugs like alcohol.
The authors concluded that this disconnect limits the potential for meaningful discussions about the risks and benefits of cannabis use during pregnancy. “Pregnant people describe using cannabis as medicine for pregnancy symptoms and other health conditions, yet they experience providers as viewing and treating cannabis like a harmful recreational substance,” the study noted.
Broader Implications and Future Directions
The implications of this mistrust extend beyond individual patient-provider relationships. As cannabis policies evolve and more states legalize its use, healthcare providers must adapt their approaches to discussing cannabis with patients. Increased education and open dialogue are essential for addressing the concerns of pregnant individuals and ensuring they receive appropriate care.
Moreover, further research is needed to understand the long-term effects of cannabis use during pregnancy and to develop guidelines that can help healthcare providers navigate these discussions effectively. The CDC emphasizes the need for more comprehensive studies to clarify the health impacts of cannabis on pregnant individuals and their newborns.
Verbatim Quotes
- “The rapidly changing context could affect how patients and/or providers approach the topic in health care settings,” — Authors of the study in *Women’s Health Issues*
Conflicting Reports & Gaps
While the CDC outlines potential health risks associated with cannabis use during pregnancy, the evolving literature suggests that many patients still find value in its use for symptom management. This discrepancy highlights the need for more nuanced discussions and research to bridge the gap between patient experiences and provider perceptions.
